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We propose a microﬂuidic system that generates nanovesicles (NVs) by slicing living cell membrane with
microfabricated 500 nm-thick silicon nitride (SixNy) blades. Living cells were sliced by the blades while
ﬂowing through microchannels lined with the blades. Plasma membrane fragments sliced from the cells
self-assembled into spherical NVs of ~100e300 nm in diameter. During self-assembly, the plasma
membrane fragments enveloped exogenous materials (here, polystyrene latex beads) from the buffer
solution. About 30% of beads were encapsulated in NVs, and the generated NVs delivered the encap-
sulated beads across the plasma membrane of recipient cells, but bare beads could not penetrate the
plasma membrane of recipient cells. This result implicates that the NVs generated using the method in
this study can encapsulate and deliver exogenous materials to recipient cells, whereas exosomes secreted
by cells can deliver only endogenous cellular materials.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Exogenous material delivery such as drug and gene delivery has
wide applications in therapeutics. For these purpose, trans-
membrane delivery is critical with minimal toxic effect. Recently,
exosomes (~30e200 nm vesicles composed of a lipid bilayer)
secreted by cells into the extracellular environment, are used as
nanocarriers for drugs and nucleic acids due to their low toxicity
and nano-scale size [1e8]. Due to these unique characteristics,
exosomes have possible therapeutic applications [9e11]. However,
utilizing exosomes for research is difﬁcult because they are secreted
in extremely small numbers (~0.1 mg frommillion cells for 24 h) and
isolation of exosomes requires a lengthy process that give only a
low yield [3,4,12].
Liposomes are synthetic vesicles composed of a lipid bilayer
being also used as nanocarriers. Most liposome production
methods use organic solvent to form and deposit planar lipidical Engineering, POSTECH,
90-784, Republic of Korea.
279 5899.
Ltd. This is an open access article ubilayers due to insolubility of lipids in aqueous solution [13]. The
planar lipid bilayers are mechanically agitated using extrusion or
ultrasound, and broken into small free-standing pieces, which then
tend to self-assemble into spherical liposomes to reduce their free
energy [14e18]. If the planar lipid bilayers self-assemble in some
materials dissolved aqueous solution, the lipid bilayers encapsulate
the materials [19e22]. Recently, the liposomes encapsulating ma-
terials were demonstrated using microﬂuidic encapsulation sys-
tems [23,24]. Although liposomes have similar morphology to
those of cell-secreted exosomes and can encapsulate materials, li-
posomes have critical drawbacks. The liposome generation proce-
dure requires organic solvents and chemical additives which may
not be biocompatible [25e28]. Furthermore, the generated lipo-
somes lack functional membrane proteins which have important
functions in initiating signal pathways in recipient cells. Despite
these limitations, the liposome generation procedure provides an
insight into lipid bilayer self-assembly.
Cellular plasma membranes are also composed of lipid bilayers
which have the ability to self-assemble into vesicles. We extruded
living cells through micro-sized channels to generate NVs
[7,29e31]. The NVs enclose cellular contents from origin cells, such
as membrane proteins, cytosolic proteins and RNAs, and can also
deliver endogenous RNA into cells [29]. To investigate the effect of
NV treatment of cells, we developed a polycarbonate device thatnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. (a) Schematic structure of cell-slicing device. It is composed of the silicon part
with 500 nm-thick SixNy cantilever-blades and the PDMS part with microchannels and
an inlet port and an outlet port. (b) The silicon part has parallel SixNy cantilever-blades
which have 1 mm-long protrusion and 500 nm-thickness. (c) A schematic of NVs
generation by slicing cells. As cells ﬂowed through microchannels, 1) the cells moved
down and up due to the ﬂow at the groove and 2) the cells were sliced by SixNy blades
3) into plasma membrane fragments. 4) The plasma membrane fragments self-
assembled into small NVs, which were collected along with unsliced cells and cell
debris at the outlet.
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delivered into skin ﬁbroblasts, and the treated skin ﬁbroblasts
proliferated faster than did non-treated cells [8]. Although the NVs
generated by extrusion method were effective in deliver endoge-
nous cellular materials, NVs that can be loaded with exogenous
materials such as genetic materials are necessary for extensive
applications, and the loading efﬁciency of exogenous materials are
closely related to the process of NV generation. In the previous
method, the plasma membranes are attached to the wall of
microchannels/micropores, elongated, and suddenly broken down
without enough opening to the surround buffer, and the NVs
generated using this method is not effective to encapsulate exog-
enous materials.
In this article, we designed a cell-slicing system to generate NVs
from living cells; this method exploits the self-assembly of plasma
membrane fragments. An array of 500 nm-thick low-stress silicon
nitride (SixNy) blades along microchannels was fabricated to slice
the plasma membranes of cells ﬂowing through the device. When
sliced from a living cell, a free-standing piece of plasma membrane
with intact lipid bilayer structure forms a vesicle that contains
cellular contents in the origin cells and exogenous materials. This
approach to generating exosome-like NVs will provide a promising
strategy for delivery of exogenous drugs and genes.
2. Materials & methods
2.1. Device design and fabrication
The cell-slicing device (Fig. 1) consists of two parts: a silicon
substrate with SixNy blades and a polydimethylsiloxane (PDMS)
block with lithographed microﬂuidic channel array (Fig. 1a). The
SixNy blades on the silicon substrate are 1 mm long and 500 nm
thick and are spaced 23 mm apart (Fig. 1b). The microﬂuidic chan-
nels in the PDMS part are 2.5 mm long, 50 mm high and have four
different widths (10, 50, 100, 200 mm) with a ﬁxed total cross sec-
tion (8  108 m2); these dimensions were decided because the
embryonic stem (ES) cells (~5 mm diameter) clogged the micro-
channels when the channel height is less than 10 mm. In contrast,
the NV generation yield decreased with the elevated height. After
aligning and assembling the silicon substrate and the PDMS block,
the SixNy blades are perpendicularly aligned in the middle of the
PDMS channel array to slice the plasma membranes of incoming
cells.
The device was fabricated using conventional bulk silicon
fabrication processes and soft lithography. The cantilever-blades
were fabricated from SixNy. First, a 100 nm thick silicon oxide
(SiO2) layer was thermally grown and a 500 nm thick SixNy layer
was deposited on a (100) silicon wafer by low pressure chemical
vapor deposition. For low-stress nitride deposition, SiH2Cl2 gas
(100 ccm) was used more than NH3 gas (40 ccm), so the Si/N ratio
was estimated as 1.1 [32]. On the wafer, the pattern for SixNy can-
tilevers was formed by a lithography process using AZ-4330
photoresist. The patterned SixNy layer on the wafer was over-
etched using inductively-coupled plasma reaction-ion-etching to
develop the pattern on the layer. The SiO2 layer exposed through
the dry-etched SixNy layer was removed by buffered oxide etching
to expose single-crystal silicon substrate. The silicon wafer was
anisotropically wet-etched using 40% KOH at 70 C for 1 h.
The pattern for microﬂuidic channels in the PDMS part was
fabricated using soft lithography. SU-8 2100 was spun with 50 mm
thickness and lithographically patterned to form the microﬂuidic
channel array, an inlet chamber and an outlet chamber (Fig.1a). The
wafer with the SU-8 pattern was used as a master for the PDMS
mold. A mixture of nine parts PDMS silicon elastomer base and one
part curing agent was cured at 65 C for 2 h after bubbles in themixture were removed. The cured PDMS part was aligned and
bonded to the silicon part by oxygen plasma treatment, then baked
on a hotplate at 150 C for 2 h to achieve strong bonding. After
connecting tubes to the inlet and outlet port of the device, the
assembled apparatus was washed by passing 75% ethanol and
deionized water sequentially through the tubes.
2.2. Cell slicing in microchannel
Living cells were entrained in the ﬂowing medium and plasma
membrane of the cells were sliced when they touched the edge of a
cantilever-blade (Fig. 1c). The cross section of a microchannel in
J. Yoon et al. / Biomaterials 59 (2015) 12e2014PDMS part is 50 mm  (10, 50, 100 or 200 mm) and the length is
2.5 mm with 75 cantilever-blades in series.
2.3. Study of plasma membrane fragment self-assembly
After the plasma membrane were fragmented, they spontane-
ously self-assembled in the aqueous phase to form NVs (Fig. 2a). By
the second law of thermodynamics, the excess Gibbs free energy of
the vesicle is
dG ¼ SdT þ VdP þ dEb þ dEl (1)
where S is entropy, T is temperature, V is volume, P is pressure, Eb is
the bending free energy and El is the contour free energy [33,34]. If
we assume that 1) the fragments sliced from plasma membranes
are planar lipid bilayers, 2) the fragments consist only of phos-
pholipids and 3) T and P are constant, then the excess Gibbs free
energy of the vesicle is just the sum of Eb and El. For simplicity, if
only planar and spherical shapes are considered, the standard
bending free energy per unit area eb of the lipid bilayer membrane
is
eb ¼
dEb
dA
¼ k
2
ðc1 þ c2Þ2  kc0ðc1 þ c2Þ þ kc1c2 (2)
where k is the bending rigidity and k is the bending modulus [14].
The principal curvatures c1 and c2 are identical in this analysis. The
spontaneous curvature c0 is zero because the lipid bilayer is
assumed to be symmetric. The contour free energy per unit length
El is
El ¼
dEl
dl
¼ g (3)
where g is the edge tension [34]. Then, the total Gibbs free energy
simpliﬁes to
GðqÞ ¼
Z
ebdAþ
Z
eldl ¼ 2pkb½1 cosðqÞ þ 2gðpAÞ0:5 sin

q
2

(4)Fig. 2. (a) A schematic representation of spontaneous self-assembly from planar
membrane. (b) Stable shape of lipid bilayer along with size according to minimum free
energy.in terms of the angle q (Fig. 2a), where A ¼ 2pr2½1þ cosðqÞ is the
area of the membrane and l ¼ 2pr sinðqÞ is its contour length. The
radius r of the sphere is the inverse of the principal curvature, and
kb ¼ 2kþ k . To analyze parameters, the Gibbs free energy is con-
verted into dimensionless form
GðqÞ ¼ G
2pkb
¼ 1 cosðqÞ þ a sin

q
2

(5)
where a ¼ ðg=kbÞðA=pÞ0:5 determines whether the planar or
spherical shape is more stable (has minimum free energy). When
a < 2, the planar shape has the minimum free energy; when a > 4,
the spherical shape has the minimum free energy. However, when
2  a  4, energy is needed to change the shape. By using
reasonable values of kb and g, the information about the effects of a
can be used to identify which geometry is the most stable along
with the radius of the sphere. The empirical values are
kb ~ 5e25 kbT and g ~ 1e2 kbT/l, where kb is the Boltzmann constant
[33,35]; i.e., both planar and spherical lipid bilayers ranging from
50 nm to 200 nm are stable and must overcome an energy barrier
to change shape; lipid bilayers > 200 nm should be spherical
(Fig. 2b). Therefore, vesicles >50 nm may be considered stable in
the aqueous phase when they are spherical.
2.4. Cell culture
Murine embryonic stem cells (ES-D3; ATCC, Manassas, VA) were
maintained in knockout DMEM (Gibco) including 15% replacement
fetal bovine serum (FBS, Gibco), 4 mM L-glutamine (Sigma),
100 mg mL1 penicillin-streptomycin (Gibco), 10 ng mL1 leukemia
inhibitory factor (ORF genetics) and 0.1 mM 2-Mercaptoethanol
(Sigma).
NIH 3T3 (ATCC, CRL-1658) cells were maintained in DMEM
(Hyclone) including 10% FBS (Hyclone) and 100 mg mL1 penicillin-
streptomycin (Gibco). Proteins and RNAs in NIH 3T3 cells were
isolated and used as negative controls of experiments for charac-
terization of NV contents.
Mouse embryonic ﬁbroblasts expressed green ﬂuorescent pro-
tein (MEF-GFP) were isolated from C57BL/6-Tg(ACTB-EGFP)10sb/J
mice using a slightly modiﬁed protocol [36]. The isolation from
C57BL/6-Tg(ACTB-EGFP)10sb/J mouse was approved by the Insti-
tutional Animal Care and Use Committee at POSTECH, Pohang,
Republic of Korea (approval number: 2013-01-0016). MEF-GFP cells
were maintained in DMEM including 10% FBS and 100 mg mL1
penicillin-streptomycin (Gibco).
2.5. NV generation and isolation
The ES cells were suspended to 1  107 cells mL1 with PBS
buffer. The cell-suspension buffer (1 mL) was loaded in a 1 mL
disposable syringe. The syringe was connected to the inlet of the
microchannels; another syringe was connected to the outlet of the
microchannel to collect the sample. The cell-suspension buffer was
passed 11 times through the device with hand (~1 mL/min) at 4 C.
The sample from the outlet was pre-cleaned by centrifugation at
210 g-force for 15 min to eliminate unsliced cells. The supernatant
was loaded on a 10%e30% (weight/volume percent of iodixanol)
Opti-prep gradient solution in an ultracentrifuge tube. The tube
was centrifuged at 100,000 g-force for 1 h at 4 C to separate the
NVs from cell debris. The entire band between 10% and 30% Opti-
prep was collected and used in the following assays.
NVs could also be generated from plasma membrane fragments
caused by shear force instead of by slicing while they pass through
the device [29], or by natural exosome secretion by the cells
[4e6,11]. To quantify these effects, the above two tests were
Actin Forward ACGTTGACATCCGTAAAGAC
Reverse GCAGTAATCTCCTTCTGCAT
Oct 3/4 Forward AGACCATGTTTCTGAAGTGC
Reverse GAACCATACTCGAACCACAT
Nanog Forward AGGGTCTGCTACTGAGATGCTCTG
Reverse CAACCACTGGTTTTTCTGCCACCG
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had neither cantilever blades nor grooves (shear stress rupture) but
was otherwise identical to the test device, and on samples of buffer
containing cells that had been stored at 4 C for 6 h (exosome
secretion).
To conﬁrm the effect of ﬂow rate on the NV generation efﬁ-
ciency, ES cell-suspension buffer was passed 11 times through the
200 mm-wide-channel using a syringe pump with 50, 100, 200 ml/
min at 4 C. The samples from the outlet were collected and done
with equivalent NV isolation process.
2.6. NV size analysis and quantiﬁcation
The quantity of isolated NVs was estimated using a Bradford
protein assay (Bio-Rad Laboratories) to measure the surface pro-
teins tethered on the membrane of NVs [1,4]. The numbers and
sizes of particles were measured using a nanoparticle tracking
assay (NTA, Nanosight, Nanosight LM10-HS system). Concentrated
sample was diluted to 0.5 mg mL1 with PBS. Samples (1 mL) were
loaded on a stage after cleaning it with HEPES buffered saline
buffer. Each sample was measured three times.
The size distributions of NV generated from each of the 10, 50,
100 and 200 mm-wide-channels were measured using a dynamic
laser scattering (DLS) instrument (Zetasizer 3000HSA, Malvern
Instrument). A 1mL sample of NVs was quantiﬁed and adjusted to a
concentration of 5 mg mL1 for measurement. Morphology and size
of the NVs were examined using a transmission electron micro-
scope (TEM, Joel 10011, Japan). A 5 mL sample was loaded on the
Formavar carbon ﬁlm (Electron Microscopy Science) for 10 s and
removed using ﬁlter paper. Then 7 mL of 2% uranyl acetate was
loaded on the grid for 10 s and the residue was removed using ﬁlter
paper. The grid was completely dried for 30 min at room temper-
ature under ﬁlter paper. The following tests were conducted for
NVs from 50, 100 and 200 mm-wide-channels only, because gen-
eration of NVs with 10 mm-wide-channels required too much time
due to low ﬂow rate.
2.7. Characterization of NV contents
Protein content of each sample (ES-D3, NIH-3T3, NVs) was
measured by extracting proteins using a mixture of RIPA buffer and
protease inhibitors for 10 min. The samples were centrifuged at
10,000 g-force for 10 min and the supernatants were collected in
different tubes. The protein concentration was measured using a
BCA protein assay kit (Thermo scientiﬁc). The isolated proteins
were used as samples for western blotting to conﬁrm intercellular
proteins and membrane proteins.
RNA of each sample (ES-D3, NIH-3T3, NVs) was quantiﬁed using
spectrophotometry and reverse transcription polymerase chain
reaction (RT-PCR). To prepare the samples for analysis, they were
lysed using TRI reagent (Sigma) and incubated for 5 min in room
temperature. The mixture was mixed with chloroform (Sigma) and
centrifuged at 13,500 g-force for 10 min to separate the organic
phase from the aqueous phase. As much of the aqueous phase as
possible was collected and mixed with the same volume of IPA
(Sigma). The sample was stored at 20 C for 20 min, then
centrifuged at 13,500 g-force for 10 min. The supernatant was
carefully removed to avoid breaking the RNA pellet. Then the
remaining IPA was removed by rinsing in 75% ethanol and centri-
fuged at 13,500 g-force for 10 min. The ethanol was removed and
the pellet was totally dried. The RNA pellet was dissolved in
nuclease-free water (Ambion) and the RNA concentration was
measured using a spectrophotometer (GENOVA).
Western blotting was performed to conﬁrm the existence of
characteristic proteins in NVs. Isolated proteins (5 mg) from NVswere mixed with 5 loading dye, then denatured proteins were
separated in 10% SDS-PAGE gel at 120 V for 2 h. The proteins were
transferred to polyvinylidene ﬂuoride membrane at 390mA for 2 h.
The membrane was blocked using 5% non-fat dry milk in PBS.
Primary antibodies in 5% non-fat dry milk were incubated with the
membrane overnight at 4 C. After washing the membrane three
times with 0.05% tween 20 in TBS, second antibodies were also
incubated with the membrane for 1 h at room temperature. The
targeted proteins were visualized using a chemiluminescent sub-
strate. The antibodies used were: Anti-actin (Santa Cruz), Anti-
ICAM-1 (biorbyt), Anti-nanog (Milipore), anti-mouse HRP (Santa
cruz) and Anti-rabbit HRP (Santa cruz). Primary antibodies were
diluted 1:1000 and secondary antibodies were diluted 1:5000.
The isolated RNA was used as the sample for RT-PCR to conﬁrm
the existence of RNA in NVs. Complementary DNA (cDNA) tran-
scripts were obtained using a reverse transcription kit from 1 mg of
RNA. Reverse transcription was performed at 42 C for 70 min and
70 C for 15 min. Actin (200 bp), Oct 3/4 (100 bp) and Nanog
(400 bp) sequences were ampliﬁed with the following primers.PCR was performed in tubes containing 2 mL of the cDNA and
48 mL of a master mixture. The PCR conditions consisted of 1)
denaturation at 94 C for 2 min, 2) 32 cycles of ampliﬁcation at
94 C for 30 s each, 52 C for 1 min and 72 C for 1 min and 3)
extension at 70 C for 5 min. For analysis of the PCR products, each
sample was run on a 2% agarose gel (30 min, 100 mV), stained with
SYBR®Green (molecularprobe) for 10min then photographed using
a BioDoc-It imaging system (UVP).
2.8. Delivery of ﬂuorescent polystyrene beads and confocal
microscopy
To assess whether the NVs can encapsulate and deliver exoge-
nous materials into cells, the device was used to generate NVs that
contained red ﬂuorescent (RF) polystyrene (PS) beads (22 nm in
diameter, Thermo scientiﬁc). Stoke's diameters of potential exog-
enous materials are RNAs, DNAs, proteins and plasmids, usually
smaller than 20 nm or approximately 20 nm. In term of size,
22 nm PS bead was used as an indicator for the encapsulating
ability of NVs. Additionally, the ﬂuorescent intensity of the poly-
styrene bead standard was directly proportional to bead concen-
tration, which can give more accurate evaluation of encapsulation
efﬁciency.
To encapsulate beads within NVs, bead suspensions (0.3 mL of
0.1% solids) were diluted in ES cell suspension (1 107 cells in 1 mL
PBS) which was then passed through the cell-slicing micro-
channels. To isolate the bead-encapsulating NVs, the sample from
the outlet was pre-cleaned, loaded on a 10%e30% Opti-prep
gradient solution in an ultracentrifuge tube, and then centrifuged
at 100,000 g for 1 h. The entire band between 10% and 30% Opti-
prep concentrations was collected and diluted to have the initial
volume (1.3 mL). Encapsulation efﬁciency (EE) of red ﬂuorescent
beads in NVs was determined using ﬂuorescent intensity measured
by a plate reader (BECKMAN COULTER). EE was deﬁned as 100(Ie/It),
where It is the total red ﬂuorescent intensity of the origin bead
solution and Ie is the intensity of samples collected after
ultracentrifugation.
Fig. 3. NVs from cell-slicing device have spherical membrane structure of
~100e300 nm in diameter. (a) Size distribution and (b) mean diameters of the samples
from three microchannel width (10, 50, 100 and 200 mm) measured using DLS with
equivalent protein amount. (c) TEM images of the samples.
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bead-aggregated NVs were generated and the EE was determined.
The ES cell suspension (1  107 cells in 1 mL PBS) from the outlet of
the microchannels was mixed with bead solutions (0.3 mL of 0.1%
solids) and the bead-aggregated NVs inmixturewere isolated using
the equivalent isolation process.
To evaluate whether NVs can deliver exogenous materials into
cells, MEF-GFP cells were treated with bare beads, bead-
encapsulating NVs and bead-aggregated NVs. MEF-GFP cells
(3.5 104 cells) were seeded on a 0.2%-gelatin-coated confocal dish
(SPL). The bead-encapsulating NVs (10 mg) and bead-aggregated
NVs (10 mg) were diluted in cultured media and the bead solu-
tions were also diluted to have equivalent red ﬂuorescent intensity
of bead-aggregated NVs. Twelve hours after seeding, the MEF-GFP
cells were incubated in the media for 6 h. The samples were ﬁxed
and dyed with Hoechst (Sigma), then photographed using a
confocal microscopy (Carl Zeiss, LSM 510 Meta).
3. Results & discussion
3.1. NV generation
When the cell suspension buffer ﬂows through the device
(Fig. 1c), (1) the cells run down and up due to the groove geometry
and (2) touch the blade which is sharp enough to slice the plasma
membrane [37]. (3) The plasma membranes are sliced to planar
fragments. If the size are less the 50 nm, the planar shape remained
planar (Fig. 2b). Meanwhile, if the size are larger than 50 nm, (4) the
planar fragments start to self-assembled into NVs, depending on
their size, as explained inMaterials andMethods. The samples from
the outlet were collected and NVswere separated from the unsliced
cells and cellular debris after several isolation processes described
in Materials & Methods. The diameters of NVs were measured us-
ing DLS and the membrane structures were observed in TEM im-
ages (Fig. 3).
The size distribution of NVs from 10 mm-wide-channels had a
peak at ~90 nm, but the distribution of 50 and 100 mm-wide-
channels had the same peak at ~100 nm (Fig. 3a). The diameter of
NVs from 200 mm-wide channels had a peak at ~300 nm. The mean
diameters of NVs from 10, 50, 100 and 200 mm-wide-channels were
99± 19.18,123± 28.11,143± 50.59 and 307± 76.66 nm, respectively
(Fig. 3b). The widths of the NV peaks increase as the channel width
increased. At all channel widths, the NVs had enclosed spherical
membrane structures (Fig. 3c). The TEM images showed a similar
size tendency as the DLS data. The results indicate the diameter of
NVs increased, as the width of microchannels increased.
The relationship between the channel size and vesicles size may
come from the length of sliced membrane fragments. The channel
size is proportional to Reynolds number (Re), ratio of inertial force
to viscous force. In these rectangular channels, Re is proportional to
hydraulic diameter, 2  (50 mm  width)/(50 mm þ width). The
hydraulic diameter increases as width increases, which means
higher inertial force, and increases the impulse with the blades. So
the plasma membranes will be larger sliced and self-assembled to
bigger NVs.
3.2. Quantiﬁcation of NVs
Themean protein amount and quantity of NVs generated from 1
million ES cells were measured as ~20 mg and ~150  108 particles,
respectively (Fig. 4a,b); The amount of NVs based on Bradford
protein assay was ~100 times larger than the amount of exosomes
from same number of cells [4]. In detail, the amounts of proteins of
NVs from 50 to 100 mm-wide-channels were lower than the
amount of protein of NVs from 200 mm-wide-channels, but thenumber of NVs was similar. The result may occur because the
amount of proteins in an equivalent number of NVs would increase
as the size of NVs increase; therefore, quantifying the amount of
protein to determine the quantity of NVs is only valid when the NVs
are of same size.
In the controls, the amount of proteins in NVs produced as a
result of cell disruption by shear forces using a ﬂat surface device
[29] was ~1/8 times that produced by cell slicing. The number of
particles produced by shear stress was ~1/7 times the number of
particles produced by cell slicing. Also, the amount of proteins in
exosomes secreted by cells stored at 4 C during the experiment
was negligible compared with those in generated NVs [3,4,12].
These results demonstrate that the cell-slicing microdevice can
generate NVs using SixNy blades and that the main cause of vesicle
generation is the presence of the blades, not the shear stress by
shear force by channel wall.
The effect of ﬂow rate on NV generation efﬁciency was
conﬁrmed using NTA (Fig. 4c). When ﬂow rate was 50 and 100 ml/
min, the number of NVs was (180 ± 10.0)  108 and
(191 ± 5.57)  108. When the ﬂow rate increased to 200 ml/min, the
number of NVs was decreased to (137 ± 26.9)  108. Meanwhile,
protein amounts by Bradford assay showed that higher ﬂow rate
provided more membrane proteins (data not shown). These results
indicate that as ﬂow rates increase, the sizes of NVs will increase.3.3. Quantiﬁcation of NV components
The quantities of total proteins and RNAs in the NVs increased
linearly with the quantity of generated NVs, as is observed in
exosome quantiﬁcation [38,39]. For quantitative evaluation of the
NV generation by the device, total proteins and total RNAs in NVs
Fig. 5. (a) Total protein and (b) RNA amount in 106 ES cells and NVs from the equiv-
alent ES cells. (c) Isolated protein and (d) RNA amount in 100 mg of NVs. The data were
displayed mean ± SD (n ¼ 3, respectively).
Fig. 4. Samples from different condition were compared: Flat; ﬂowing through the
microchannel with ﬂat surface, Blade; ﬂowing through the microchannels with
cantilever-blades and Stored cell suspension; just storing at 4 C for 6 h. (a) Protein
amount of the samples from 1 million ES cells was measured with the Bradford protein
assay after several puriﬁcation steps. (b) NTA measurements of the number of particles
of the samples from 106 ES cells. (c) NTA measurements of the number of particles of
samples according to ﬂow rate from 106 ES cells. The data were displayed mean ± SD
(n ¼ 3, respectively).
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number of ES cells used in NV generation. The width of the
microchannel had little effect on the amount of protein or RNA in
the NV membranes produced from 1  106 ES cells. The total pro-
tein in NVs from 1 106 ES cells (~30 mg) was ~1/8 of the amount of
protein isolated from the same number of ES cells (~250 mg, Fig. 5a).
The total RNAs in NVs from 1  106 ES cells (~1.5 mg) was ~1/12 of
the RNAs isolated from the same number of ES cells (~18 mg, Fig. 5b).
The result reveals that ~1/10 of ES cell components were enveloped
in the membrane of NVs.
The concentration of proteins and RNAs in equivalent amount of
NVs was measured. Total protein quantity in 100 mg of NVs was
measured as ~195 mg using BCA assay. The width of the micro-
channel had no consistent effect on protein concentration (Fig. 5c),
but RNA concentration decreased from 10.5 mg in 50 nm-wide
microchannel to 4.79 mg in 200 nm-wide microchannel (Fig. 5d).3.4. Components of NVs
The NVs were generated from fragments of sliced ES cells, so the
NVs are expected to have cellular contents such as a lipid bilayermembrane, membrane proteins and intracellular proteins and
RNAs. Oct 3/4 was used as the representative marker of ES cells, and
ICAM-1 was used as a marker of plasmamembrane protein [40,41];
they were observed in samples from ES cell and in generated ves-
icles (Fig. 6a). This observation indicates that the NVs include
membrane protein and that the lipid bilayer membrane of the
vesicle was directly derived from the plasma membrane of the cell.
Oct 3/4 and b-actin are intracellular proteins in ES cells; these
proteins were detected in samples from ES cells and NVs; therefore
the NVs contain both membrane proteins and intracellular proteins
from the lipid bilayer membrane of the original ES cells.
RT-PCR detected Oct 3/4, Nanog and b-actin mRNAs in ES cells
and NVs (Fig. 6b). This reveals that the NVs enclose intracellular
RNAs from ES cells. The RNA proﬁle for ES cells had three peaks
(small RNA and two rRNA); the RNA proﬁle for all NVs also had
three peaks that correspond to the ES cell RNA proﬁle (Fig. 6c).
These results show that the NVs were composed of cellular com-
ponents (membrane proteins, intracellular proteins and mRNAs)
from the original ES cells. The presence of miRNA, rRNA and tRNA
suggests that the NVs can be used as vehicles for RNA delivery.
3.5. Exogenous material encapsulation efﬁciency
The bead-encapsulation efﬁciency of NVs was assessed by
measuring ﬂuorescence intensity. Bead-encapsulating NVs were
generated by ﬂowing ES cell suspension mixed with RF beads so-
lution through the cell-slicing system. During the process, the
beads could be encapsulated in NVs, aggregated to the lipid
membrane of NVs or remained without any interaction with NVs.
After the sample was isolated by using gradient ultracentrifugation
(Fig. 7a), the EE of the sample was measured ~60% (Fig. 7b). The
contribution to the EE of all of these cases need to be considered for
accurate evaluation of the EEs.
First, the bare beads cannot exist in the layer of the discontin-
uous density gradient (10e30%) by themselves due to the density,
the beads in the layer were only inside the NVs (encapsulating) or
outside the NVs (aggregated). Accordingly, the contribution of the
bare bead to the EE after the equivalent gradient centrifugationwas
just few percent, andmay be negligible (Fig. 7b). Therefore, only the
EE from bead-encapsulating NVs and bead-aggregated NVs need to
be considered. To measure the EE of the bead-aggregated NVs, the
Fig. 6. (a) Western blotting of ES cell proteins using ICAM-1, Nanog and Oct3/4. (b) RT-PCR for ES cells, NIH-3T3 ﬁbroblast and NVs from ES cells. (c) RNA proﬁles from Bioanalyzer™
for ES cells and NVs.
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However, this separation is difﬁcult, and the bead-aggregated NVs
was separately generated by mixing bare bead and NVs as
described in Materials and Methods (Fig. 7a). Then, the bead-
aggregated NVs were isolated in the same way, and the EE of
bead-aggregated NVs was measured about ~30% (Fig. 7b). There-
fore, the corrected EE of bead-encapsulating NVs was estimated as
~30% by subtracting the EE of the bead-aggregated NVs from the EE
of the sample generated by ﬂowing ES cell suspension mixed with
RF beads solution through the cell-slicing system.
In addition to aggregation, the ﬂuorescent intensity can be
originated from lipid monolayer coated beads which could
potentially be isolated due to density change. To rule out the
possibility, the size distribution of bead-encapsulating NVs, bead-
aggregated NVs generated with 200 mm wide channel, and 22 nm
beads were measured using DLS (Fig. 7c). Beads had sharp peak at
22 nm. The bead-encapsulating NVs had similar size distribution
with NVs. If there are bead surrounded with lipid monolayer,
peaks below the 100 nm should exists. No peak around 100 nm in
size distribution of bead-encapsulating NVs suggests that there
are no beads outside the membrane of NVs. However, size dis-
tribution of bead-aggregated NVs had two peaks at ~100 nm and
600 nm, which means there are many beads outside the mem-
brane of NVs. The result reveals that the sliced plasma membrane
fragments can encapsulate ~30% of materials in surrounded buffer
when the fragments are self-assembled into NVs. For comparison,
the NVs that encapsulated RF beads were generated using
extrusion method and isolated using the same process [7]. The
ﬂuorescent intensity of the NVs was just ~35%, which is similar to
that of the bead-aggregated NVs (Fig. 7b). This result indicates
that the NVs generated by extrusion may not encapsulate the
beads effectively.There is a possibility that the detergent in PS bead solution may
affect the experimental results. Although detergent was generally
dissolved in the original bead solution, the trace concentration of
detergent in original bead solution was as low as ~0.1% provided by
the manufacturer. After mixing bead with PBS, the ﬁnal concen-
tration was ~0.0002%, and considered to have negligible effect on
NV formation.
3.6. Delivery of polystyrene bead encapsulated NVs
By using PS beads as representative of exogenous materials, the
delivery ability of NVs was conﬁrmed. MEF-GFP cells treated with
bead-encapsulating NVs had more red ﬂuorescent dots in their
membranes than did the cells treated with bead-aggregated NVs
(Fig. 7d). In addition, the cells treated with bare bead with equiv-
alent ﬂuorescent intensity of bead-encapsulating NVs showed no
red dots in their membrane, although the beads <500 nm in
diameter can be internalized by non-phagocytic cells [42]. These
results implicate that materials to which the plasma membrane is
impermeable can be delivered to cells by being encapsulated in the
NVs.
4. Conclusion
NVs that can encapsulate and deliver exogenous materials were
generated by passing cells through a cell-slicing microﬂuidic
system-on-a-chip. The sliced plasma fragments self-assembled into
NVs due the minimization of free energy of lipid bilayer. The
number of particles produced was ~150  108 per million ES cells
and their size was ~100e300 nm. Although the contents of the NVs
were compared to ES cells and identiﬁed to be similar in terms of
intracellular proteins, membrane proteins and intracellular RNAs
Fig. 7. Delivery of red ﬂuorescent beads across the plasma membrane. (a) A schematics of the experiments. (b) Encapsulation efﬁciency of beads in NVs. Bead; unaided beads,
Extrusion; bead-encapsulating NVs generated using centrifugal extrusion. The data were displayed mean ± S.D (n ¼ 3). (c) Size distribution of three samples: 22 nm bead, bead-
aggregated NVs, and bead-encapsulating NVs. (d) Confocal microscope images of MEF-GFP cells treated with bare beads and various NVs. Green: MEF-GFP, blue: Nucleus of MEF-
GFP, Red: ﬂuorescent bead. Scale bar ¼ 20 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
J. Yoon et al. / Biomaterials 59 (2015) 12e20 19(mRNAs, small RNAs and rRNAs), NVs can also encapsulate ﬂuo-
rescent beads representing exogenous materials with ~30%
encapsulation efﬁciency and deliver the encapsulated beads to
recipient cells. Therefore, unlike cell-secreted exosomes, the NVs
generated by the method introduced in this study can be used as
vehicles for delivery of drugs and exogenous biomolecules.
Acknowledgments
This work was supported by the National Research Foundation
of Korea (NRF) grant funded by the Korea government (MSIP) (No.
2011-0030075, 2011-0028845).
References
[1] L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, M.J. Wood, Delivery of
siRNA to the mouse brain by systemic injection of targeted exosomes, Nat
Biotechnol 29 (4) (2011) 341e345.[2] W. Perkins, S. Minchey, P. Ahl, A. Janoff, The determination of liposome
captured volume, Chem Phys Lipids 64 (1) (1993) 197e217.
[3] E. Segura, C. Nicco, B. Lombard, P. Veron, G. Raposo, F. Batteux, et al., ICAM-1
on exosomes from mature dendritic cells is critical for efﬁcient naive T-cell
priming, Blood 106 (1) (2005) 216e223.
[4] C. Thery, S. Amigorena, G. Raposo, A. Clayton, Isolation and characterization of
exosomes from cell culture supernatants and biological ﬂuids, Curr Protoc Cell
Biol (2006), 3.22. 1e3. 9.
[5] C. Thery, M. Ostrowski, E. Segura, Membrane vesicles as conveyors of immune
responses, Nat Rev Immunol 9 (8) (2009) 581e593.
[6] A.J. Abusamra, Z. Zhong, X. Zheng, M. Li, T.E. Ichim, J.L. Chin, et al., Tumor
exosomes expressing Fas ligand mediate CD8þ T-cell apoptosis, Blood Cells
Mol Dis 35 (2) (2005) 169e173.
[7] W. Jo, J. Kim, J. Yoon, D. Jeong, S. Cho, H. Jeong, et al., Large-scale generation of
cell-derived nanovesicles, Nanoscale 6 (20) (2014) 12056e12064.
[8] D. Jeong, W. Jo, J. Yoon, J. Kim, S. Gianchandani, Y.S. Gho, et al., Nanovesicles
engineered from ES cells for enhanced cell proliferation, Biomaterials 35 (34)
(2014) 9302e9310.
[9] K.-S. Park, K.-H. Choi, Y.-S. Kim, B.S. Hong, O.Y. Kim, J.H. Kim, et al., Outer
membrane vesicles derived from Escherichia coli induce systemic inﬂamma-
tory response syndrome, PLoS One 5 (6) (2010) e11334.
J. Yoon et al. / Biomaterials 59 (2015) 12e2020[10] H. Peinado, M. Aleckovic, S. Lavotshkin, I. Matei, B. Costa-Silva, G. Moreno-
Bueno, et al., Melanoma exosomes educate bone marrow progenitor cells
toward a pro-metastatic phenotype through MET, Nat Med 18 (6) (2012)
883e891.
[11] A.V. Vlassov, S. Magdaleno, R. Setterquist, R. Conrad, Exosomes: current
knowledge of their composition, biological functions, and diagnostic and
therapeutic potentials, Biochim Biophys Acta 1820 (7) (2012) 940e948.
[12] G. Van Niel, G. Raposo, C. Candalh, M. Boussac, R. Hershberg,
N. CerfeBensussan, et al., Intestinal epithelial cells secrete exosomeelike
vesicles, Gastroenterology 121 (2) (2001) 337e349.
[13] B. Maherani, E. Arab-Tehrany, M.R. Mozafari, C. Gaiani, M. Linder, Liposomes:
a review of manufacturing techniques and targeting strategies, Curr Nanosci 7
(3) (2011) 436e452.
[14] W. Helfrich, Stiffening of ﬂuid membranes and entropy loss of membrane
closure: two effects of thermal undulations, Eur Phys J B 1 (4) (1998)
481e489.
[15] E. Hernandez-Zapata, L. Martínez-Balbuena, I. Santamaría-Holek, Thermody-
namics and dynamics of the formation of spherical lipid vesicles, J Biol Phys 35
(3) (2009) 297e308.
[16] J.N. Israelachvili, D.J. Mitchell, B.W. Ninham, Theory of self-assembly of lipid
bilayers and vesicles, Biochim Biophys Acta 470 (2) (1977) 185e201.
[17] E. Sackmann, Membrane bending energy concept of vesicle-and cell-shapes
and shape-transitions, FEBS Lett 346 (1) (1994) 3e16.
[18] R.T. Davies, D. Kim, J. Park, Formation of liposomes using a 3D ﬂow focusing
microﬂuidic device with spatially patterned wettability by corona discharge,
J Micromech Microeng 22 (5) (2012) 055003.
[19] A. Sharma, U.S. Sharma, Liposomes in drug delivery: progress and limitations,
Int J Pharm 154 (2) (1997) 123e140.
[20] J.W. Park, Liposome-based drug delivery in breast cancer treatment, Breast
Cancer Res 4 (3) (2002) 95.
[21] Y. Perrie, G. Gregoriadis, Liposome-entrapped plasmid DNA: characterisation
studies, Biochim Biophys Acta Gen Subj 1475 (2) (2000) 125e132.
[22] J.J. Sudimack, W.J. Guo, W. Tjarks, R.J. Lee, A novel pH-sensitive liposome
formulation containing oleyl alcohol, Biochim Biophys Acta Biomembr 1564
(1) (2002) 31e37.
[23] J.C. Stachowiak, D.L. Richmond, T.H. Li, A.P. Liu, S.H. Parekh, D.A. Fletcher,
Unilamellar vesicle formation and encapsulation by microﬂuidic jetting, Proc
Natl Acad Sci U S A 105 (12) (2008) 4697e4702.
[24] Y.-C. Tan, K. Hettiarachchi, M. Siu, Y.-R. Pan, A.P. Lee, Controlled microﬂuidic
encapsulation of cells, proteins, and microbeads in lipid vesicles, J Am Chem
Soc 128 (17) (2006) 5656e5658.
[25] A. Bangham, M.M. Standish, J. Watkins, Diffusion of univalent ions across the
lamellae of swollen phospholipids, J Mol Biol 13 (1) (1965), 238eIN27.
[26] D. Deamer, A. Bangham, Large volume liposomes by an ether vaporization
method, Biochim Biophys Acta 443 (3) (1976) 629e634.[27] A. Jahn, W.N. Vreeland, D.L. DeVoe, L.E. Locascio, M. Gaitan, Microﬂuidic
directed formation of liposomes of controlled size, Langmuir 23 (11) (2007)
6289e6293.
[28] F. Szoka, D. Papahadjopoulos, Procedure for preparation of liposomes with
large internal aqueous space and high capture by reverse-phase evaporation,
Proc Natl Acad Sci U S A 75 (9) (1978) 4194e4198.
[29] W. Jo, D. Jeong, J. Kim, S. Cho, S.C. Jang, C. Han, et al., Microﬂuidic fabrication of
cell-derived nanovesicles as endogenous RNA carriers, Lab Chip 14 (7) (2014)
1261e1269.
[30] S.C. Jang, Y.S. Gho, Could bioengineered exosome-mimetic nanovesicles be an
efﬁcient strategy for the delivery of chemotherapeutics? Nanomedicine
(Lond) 9 (2) (2014) 177e180.
[31] S.C. Jang, O.Y. Kim, C.M. Yoon, D.-S. Choi, T.-Y. Roh, J. Park, et al., Bioinspired
exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to
malignant tumors, ACS Nano 7 (9) (2013) 7698e7710.
[32] N. Sharma, M. Hooda, S. Sharma, Synthesis and characterization of LPCVD
polysilicon and silicon nitride thin ﬁlms for MEMS applications, J Mater (2014)
2014.
[33] M. Antonietti, S. F€orster, Vesicles and liposomes: a self-assembly principle
beyond lipids, Adv Mater 15 (16) (2003) 1323e1333.
[34] L.A. Meijer, F.A. Leermakers, J. Lyklema, Modeling the interactions between
phospholipid bilayer membranes with and without additives, J Phys Chem U S
99 (47) (1995) 17282e17293.
[35] T. Le, U. Olsson, K. Mortensen, Topological transformation of a surfactant
bilayer, Phys B 276 (2000) 379e380.
[36] J.B. Harford, Preparation and isolation of cells, Curr Protoc Cell Biol 32 (2006).
John Wiley & Sons, Inc. [Chapter 2, 2.0.1-2.7.21].
[37] H. Jeong, T. Li, Y.B. Gianchandani, J. Park, High precision cell slicing by
harmonically actuated ultra-sharp SixNy blades, J Micromech Microeng 25 (2)
(2015) 025007.
[38] A. Savina, M. Furlan, M. Vidal, M.I. Colombo, Exosome release is regulated by a
calcium-dependent mechanism in K562 cells, J Biol Chem 278 (22) (2003)
20083e20090.
[39] A. Montecalvo, A.T. Larregina, W.J. Shufesky, D.B. Stolz, M.L. Sullivan,
J.M. Karlsson, et al., Mechanism of transfer of functional microRNAs between
mouse dendritic cells via exosomes, Blood 119 (3) (2012) 756e766.
[40] L. Tian, J.W. Catt, C. O'Neill, N. King, Expression of immunoglobulin super-
family cell adhesion molecules on murine embryonic stem cells, Biol Reprod
57 (3) (1997) 561e568.
[41] P. Fairchild, F. Brook, R. Gardner, L. Graca, V. Strong, Y. Tone, et al., Directed
differentiation of dendritic cells from mouse embryonic stem cells, Curr Biol
10 (23) (2000) 1515e1518.
[42] J. Rejman, V. Oberle, I.S. Zuhorn, D. Hoekstra, Size-dependent internalization
of particles via the pathways of clathrin- and caveolae-mediated endocytosis,
Biochem J 377 (Pt 1) (2004) 159e169.
